Nivalon Medical Produces Metal-Free Spinal Implant

Nivalon Medical Technologies has successfully produced what is claimed to be the world’s first fully patient-specific, motion-preserving spinal implant built entirely without metal, using AI-driven design and advanced ceramic 3D printing. The breakthrough device combines a proprietary zirconia-toughened alumina (ZTA) ceramic architecture that behaves like bone with a flexible elastomeric core to mimic natural spinal motion, creating a new category of spinal implant engineered to match both human anatomy and natural biomechanics.

An alternative to traditional implants manufactured in fixed sizes and made from metal alloys, Nivalon’s implant is digitally designed directly from each patient’s CT data and 3D-printed to precisely match their anatomy. The result is a bone-like ceramic structure that eliminates metal-related complications such as corrosion, ion release, stiffness mismatch, and imaging interference, while preserving natural spinal motion.

First-in-human procedures are planned for 2026.

The platform has undergone extensive independent pre-clinical validation through biomechanical, mechanical, biological, and anatomical testing conducted at the University of South Florida (USF) and the University of Connecticut Institute of Materials Science (UConn IMS).

At USF, EvoFlex implants were evaluated on the Dynamic Investigation of Spine Characteristics (DISC) simulator under six degrees of freedom motion and physiologic spinal loading, demonstrating stiffness curves and motion profiles that closely replicate native human spinal behavior. These results confirm true motion preservation, not just mechanical articulation.

At UConn IMS, compression and shear testing demonstrated major improvements in structural performance. The latest design achieved compressive loads of 14.6 kN, equivalent to approximately 1,490 kg (3,280 lbs) of force, validating the ceramic-polymer architecture under physiologic and supraphysiologic loading. Shear testing further demonstrated enhanced interface integrity and controlled progressive failure behavior.

UConn IMS also conducted simulated body fluid (SBF) immersion and SEM-EDX analysis, confirming that the ZTA ceramic supports uniform mineral deposition and biologically relevant ion interaction, demonstrating bone-like surface behavior and long-term osseointegration potential. Unlike metals, the ceramic showed consistent, controlled, and predictable biological interaction.

In addition, cadaveric pre-operative and post-operative surgical planning studies validated the accuracy of Nivalon’s digital design platform. In a complex four-level spinal reconstruction, the system successfully demonstrated precise virtual bone repositioning, restoration of sagittal balance, and proper facet joint alignment, confirming the platform’s ability to anatomically reconstruct and rebalance the spine with high precision.

This milestone was achieved through a strategic collaboration with the Youngstown Business Incubator (YBI) and its Advanced Manufacturing and Engine Tech programs. Using XJet’s NanoParticle Jetting ceramic 3D printing technology, Nivalon successfully developed and manufactured a pure ceramic, load-bearing spinal implant architecture.

SEM analysis at UConn confirmed that the printed ZTA ceramic represents a new and distinct microstructural class of biocompatible implant material.

The EvoFlex platform combines:

• Patient-specific, 3D-printed ceramic endplates matched directly to vertebral anatomy
• Bone-like ceramic material that eliminates metal corrosion, ion release, and imaging artifacts
• Flexible elastomeric core engineered to preserve native spinal motion
• Full MRI and CT compatibility
• Surgeon-controlled digital design workflow

With two issued U.S. patents and six additional patents pending, Nivalon is preparing for NIH Phase II SBIR funding, FDA PMA clinical trials, and first-in-human procedures in 2026.

Source: Nivalon Medical Technologies Inc.